Ispire Technology Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 14, 2024 and accepted by EDGAR at May 14, 2024, 16:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $30.0m | us-gaap:Revenues |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $114.6m | us-gaap:Revenues |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $23.9m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $95.3m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $6.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-07-01 to 2024-03-31 | $19.2m | us-gaap:GrossProfit |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $163.8k | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-07-01 to 2024-03-31 | $793.1k | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | −$5.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | −$10.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $255.5k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-01 to 2024-03-31 | $1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$5.9m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | −$11.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | −$0.11 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | −$0.21 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | −$0.11 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | −$0.21 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 54,347,729 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 54,287,624 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | −$16.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $1.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-03-31 | $39.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $98.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $108.1m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $69.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $72.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $35.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001213900-24-042990. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.